Beta-Blockers and Calcium Channel Blockers

On this page
  1. Direct answer
  2. What you must remember
  3. A decision sequence for cardiac patients
  4. High-yield viva angles
  5. Frequently asked questions
  6. Related topics

Direct answer

Beta-blockers and calcium channel blockers are drugs for hypertension, angina and arrhythmias that act on the heart and vessels through different receptors and channels. Beta-1 selective blockers such as metoprolol and bisoprolol are preferred in heart failure with reduced ejection fraction, while dihydropyridines such as amlodipine suit hypertension and angina. Non-dihydropyridines such as verapamil are avoided in heart failure with reduced ejection fraction because they depress contractility.

What you must remember

  • Selectivity: propranolol is non-selective, metoprolol, atenolol and bisoprolol are beta-1 selective, and carvedilol and labetalol also block alpha-1 receptors.
  • Beta-blocker indications: post-myocardial infarction, heart failure with reduced ejection fraction, angina, atrial fibrillation rate control, portal hypertension (propranolol) and migraine prophylaxis.
  • Beta-blocker cautions: asthma (non-selective agents are avoided), symptomatic bradycardia, heart block and decompensated heart failure.
  • Beta-blocker adverse effects: fatigue, bradycardia, bronchospasm, masking of hypoglycaemia and rebound tachycardia on abrupt withdrawal.
  • Dihydropyridines: amlodipine, nifedipine and felodipine are vascular-selective, causing reflex tachycardia, ankle oedema and gingival hyperplasia; amlodipine is neutral in heart failure.
  • Non-dihydropyridines: verapamil and diltiazem slow atrioventricular conduction, useful in supraventricular tachycardia and rate control, and are avoided in heart failure with reduced ejection fraction.
  • Interactions: verapamil or diltiazem with a beta-blocker risks heart block, and CYP3A4 inhibitors such as clarithromycin raise amlodipine levels.

A decision sequence for cardiac patients

A 58-year-old man with stable angina and hypertension asks whether a beta-blocker or a calcium channel blocker suits him better. The choice depends on heart rate, ejection fraction, airway disease and co-medication, and the steps below set out the order.

  1. Check the heart and the airway: assess ejection fraction, heart rate, atrioventricular conduction, and any asthma or COPD before selecting a class.
  2. Match the indication: beta-blockers suit post-infarction patients, heart failure with reduced ejection fraction and rate control, while dihydropyridines suit hypertension and angina with normal heart function.
  3. Consider a non-dihydropyridine: verapamil and diltiazem slow conduction and help supraventricular tachycardia and rate control, but are avoided in heart failure with reduced ejection fraction.
  4. Check interactions: combining verapamil or diltiazem with a beta-blocker risks heart block, and co-prescribed CYP3A4 inhibitors raise dihydropyridine levels.
  5. Titrate and watch side effects: monitor heart rate and blood pressure, expect fatigue and ankle oedema, and watch for bronchospasm and masked hypoglycaemia in diabetics.
  6. Taper rather than stop: withdraw beta-blockers gradually over days to weeks, since sudden stopping can cause rebound tachycardia and ischaemia.

High-yield viva angles

Viva questions usually test whether the drug suits the heart's pump function and the airway.

  • Trap: giving verapamil or diltiazem in heart failure with reduced ejection fraction Correct: these are negative inotropes that worsen the pump, so amlodipine or an evidence-based beta-blocker is used instead.
  • Trap: using a non-selective beta-blocker in asthma Correct: blocking beta-2 receptors causes bronchospasm, so non-selective agents are avoided in asthma.
  • Trap: choosing propranolol as routine first-line therapy for uncomplicated hypertension Correct: propranolol is non-selective and reserved for specific indications such as portal hypertension and migraine prophylaxis.

Frequently asked questions

Why are non-dihydropyridine calcium channel blockers avoided in heart failure?

Verapamil and diltiazem are negative inotropes that depress myocardial contractility, which worsens heart failure with reduced ejection fraction. Amlodipine, a dihydropyridine, is neutral and can be used in heart failure. Evidence-based beta-blockers are preferred for the heart failure itself.

Which beta-blockers are used with caution in asthma?

Cardioselective beta-1 blockers such as metoprolol, bisoprolol and atenolol are used with caution in asthma, since they have less effect on beta-2 receptors in the airway. Non-selective agents such as propranolol are avoided because they can precipitate bronchospasm. Any asthma patient needs close monitoring when a beta-blocker is started.

Why do dihydropyridines like nifedipine cause reflex tachycardia?

Nifedipine causes arteriolar vasodilation that lowers blood pressure, and the baroreflex responds with a rise in heart rate. Amlodipine has a slower onset and is less likely to cause this. Ankle oedema is a separate, dose-related effect of dihydropyridines.

Why are verapamil and diltiazem dangerous when combined with beta-blockers?

Verapamil and diltiazem slow atrioventricular conduction, and beta-blockers add further nodal depression. The combination can cause severe bradycardia or heart block in susceptible patients. Combined use requires careful monitoring or should be avoided.

Practise this in the PrepElephant app

Question banks, previous-year questions, mock tests and revision tools — for Beta-Blockers and Calcium Channel Blockers and NEET-PG Medicine. Free to start.

Get the free app WhatsApp